TP53 and nonpapillary renal cell carcinoma: Here, we observe that the two patient groups characterized by low miR-192 expression levels (group 1 and group 5) also display a higher p53 mutation rate than the other groups (Fisher exact test p-value: 0.0022) hence linking the regulation of miR-192 by p53 to ccRCC.